Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
This means that, potentially, hundreds of millions of people worldwide will depend on regular use of insulins, GLP-1 receptor agonists, or both
NAD+Therapy NAD+ is essential for converting nutrients into cellular energy and supporting mitochondrial function
The Role of Semaglutide in Weight Loss Semaglutide significantly reshapes the approach to weight loss by targeting the biological signals of hunger and satiety
Asparagine Asparagine can be synthesized de novo from glutamine via asparagine synthetase (ASNS)
MIS-C, multisystemic inflammatory syndrome in children